Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Early Feasibility Study (EFS) of the 'Pivot Extend' in Treatment for Tricuspid Regurgitation (SPACER Study)

NCT06877520 is registered in ClinicalTrials.gov with Tau-MEDICAL Co., Ltd. as lead sponsor.

NCT NCT06877520
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06877520 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Early Feasibility Study (EFS) of the 'Pivot Extend' in Treatment for Tricuspid Regurgitation (SPACER Study)
Lead sponsor
Tau-MEDICAL Co., Ltd.
Phase
Not applicable
Overall status
Recruiting
Start date
May 31, 2025
Completion date
December 31, 2026
Enrollment
7 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation (tr)